Why Patients Visit Their Doctors: Assessing the Most Prevalent Conditions in a Defined American Population
Jennifer L. St. Sauver(Mayo Clinic in Florida), Walter A. Rocca(Mayo Clinic), Barbara P. Yawn(University of Minnesota), Véronique L. Roger(National Heart Lung and Blood Institute), David O. Warner(Mayo Clinic in Arizona), Jon O. Ebbert(Mayo Clinic in Arizona), L. Joseph Melton(Toyota Motor Corporation (Switzerland)), Joshua J. Pankratz(Mayo Clinic in Florida), Debra J. Jacobson(Mayo Clinic), Michaela E. McGree(Mayo Clinic)
Cited by 388
Related Papers
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Epidemiology of Heart Failure
|Circulation Research|2013|1.7k
Management of Sickle Cell Disease
|JAMA|2014|1.6k
Prevalence of Monoclonal Gammopathy of Undetermined Significance
|New England Journal of Medicine|2006|1.4k